Clinical significance of a blood eosinophilia in adult T-cell leukemia/lymphoma: A blood eosinophilia is a significant unfavorable prognostic factor

Leukemia Research

Volumn 31, Issue 7, 2007, Pages 915-920

  Utsunomiya, Atae ^a   Ishida, Takashi ^b   Inagaki, Atsushi ^b   Ishii, Toshihiko ^b   Yano, Hiroki ^b   Komatsu, Hirokazu ^b   Iida, Shinsuke ^b   Yonekura, Kentaro ^a   Takeuchi, Shogo ^a   Takatsuka, Yoshifusa ^a   Ueda, Ryuzo ^b  

^a IMAMURA BUN IN HOSPITAL   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

ATLL; CCR4; Eosinophilia; Interleukin 5; Th1 Th2 balance

Indexed keywords

CHEMOKINE RECEPTOR CCR4; LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; T CELL LEUKEMIA; T CELL LYMPHOMA; TH1 CELL; TH2 CELL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; EOSINOPHILIA; EOSINOPHILS; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34249860721     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.10.017     Document Type: Article

References (22)

1. Kikuchi M., Jaffe E.S., and Ralfkiaer E. Adult T-cell leukaemia/lymphoma. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). Tumors of haematopoietic and lymphoid tissues (2001), International Agency for Research on Cancer (IARC), Lyon, France p. 200
2. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-1987). Br J Haematol 79 (1991) 428-437
3. Mosmann T.R., and Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17 (1996) 138-146
4. Ikeda H., Chamoto K., Tsuji T., Suzuki Y., Wakita D., Takeshima T., et al. The critical role of type-1 innate and acquired immunity in tumor immunotherapy. Cancer Sci 195 (2004) 697-703
5. Clutterbuck E.J., Hirst E.M., and Sanderson C.J. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood 73 (1989) 1504-1512
6. Shu S., Plautz G.E., Krauss J.C., and Change A.E. Tumor immunology. JAMA 278 (1997) 1972-1981
7. Tancrede-Bohin E., Ionescu M.A., de La Salmoniere P., Dupuy A., Rivet J., Rybojad M., et al. Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas. Arch Dermatol 140 (2004) 1057-1061
8. Inagaki A., Ishida T., Ishii T., Komatsu H., Iida S., Ding J., et al. Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors. Int J Cancer 118 (2006) 3054-3061
9. Vukelja S.J., Weiss R.B., Perry D.J., and Longo D.L. Eosinophilia associated with adult T-cell leukemia/lymphoma. Cancer 62 (1988) 1527-1530
10. Murata K., Yamada Y., Kamihira S., Atogami S., Tsukasaki K., Momita S., et al. Frequency of eosinophilia in adult T-cell leukemia/lymphoma. Cancer 69 (1992) 966-971
11. Holland S.M., and Gallin J.I. Disorders of granulocytes and monocytes. In: Kasper D.L., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., Jameson J.L., and Harris N.L. (Eds). Harison's principles of internal medicine. 16th ed. (2005), The McGraw-Hill Companies, Inc., New York 349
12. Uozumi K., Hanada S., Ohno N., Ishitsuka K., Shimotakahara S., Otsuka M., et al. Combination chemotherapy (RCM protocol: response-oriented cyclic multidrug protocol) for the acute or lymphoma type adult T-cell leukemia. Leuk Lymphoma 18 (1995) 317-323
13. Yamada Y., Tomonaga M., Fukuda H., Hanada S., Utsunomiya A., Tara M., et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 113 (2001) 375-382
14. Tobinai K., and Hotta T. Clinical trials for malignant lymphoma in Japan. Jpn J Clin Oncol 34 (2004) 369-378
15. Noma T., Nakakubo H., Sugita M., Kumagai S., Maeda M., Shimizu A., et al. Expression of different combinations of interleukins by human T cell leukemic cell lines that are clonally related. J Exp Med 169 (1989) 1853-1858
16. Yamagata T., Mitani K., Ueno H., Kanda Y., Yazaki Y., and Hirai H. Triple synergism of human T-lymphotropic virus type 1-encoded tax, GATA-binding protein, and AP-1 is required for constitutive expression of the interleukin-5 gene in adult T-cell leukemia cells. Mol Cell Biol 17 (1997) 4272-4281
17. Ogata M., Ogata Y., Kohno K., Uno N., Ohno E., Ohtsuka E., et al. Eosinophilia associated with adult T-cell leukemia: role of interleukin 5 and granulocyte-macrophage colony-stimulating factor. Am J Hematol 59 (1998) 242-245
18. Yoshie O., Imai T., and Nomiyama H. Chemokines in immunity. Adv Immunol 78 (2001) 57-110
19. Kunkel E.J., Boisvert J., Murphy K., Vierra M.A., Genovese M.C., Wardlaw A.J., et al. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am J Pathol 160 (2002) 347-355
20. Campbell J.J., Haraldsen G., Pan J., Rottman J., Qin S., Ponath P., et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400 (1999) 776-780
21. Imai T., Baba M., Nishimura M., Kakizaki M., Takagi S., and Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 272 (1997) 15036-15042
22. Ishida T., Utsunomiya A., Iida S., Inagaki H., Takatsuka Y., Kusumoto S., et al. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res 9 (2003) 3625-3634